Welcome to our dedicated page for Vita Coco Company SEC filings (Ticker: COCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Vita Coco Company's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Vita Coco Company's regulatory disclosures and financial reporting.
Vita Coco Company, Inc. Chief Marketing Officer Jane Prior reported several equity award transactions. She acquired 5,914 Performance Stock Units through vesting of a prior grant, based on 100% performance achievement, with each unit representing one share of common stock.
On the same date, she received 4,401 restricted stock units that vest in four equal annual installments, generally with shares withheld at vesting to cover taxes in non-discretionary transactions. The PSU vesting delivered 5,914 common shares, and 3,267 shares were automatically withheld to satisfy tax obligations, leaving her with 123,648 shares of common stock directly owned after these transactions. She also holds multiple non-qualified stock options with various vesting schedules, including some that are fully vested and exercisable.
Vita Coco Company, Inc. Chief Financial Officer Corey Baker reported an equity award in the form of restricted stock units. On February 20, 2026, he acquired 4,401 shares of Common Stock at a stated price of $0.00 per share as a grant or award, bringing his directly held common shares to 43,155.
The restricted stock units will vest in four equal annual installments on each anniversary of the grant date, as long as he remains in continuous service, and shares will be automatically withheld on each vesting date to cover tax obligations. The filing also updates holdings and vesting schedules for several non-qualified stock options that vest in staged annual installments through future dates.
Vita Coco Company, Inc. Executive Chairman Michael Kirban reported equity awards rather than open‑market trades. He acquired performance stock options covering 185,133 shares at 16.91 per share after specified performance conditions were met, and received 25,945 common shares via restricted stock units that vest in four equal annual installments if he remains in continuous service.
Vita Coco Company, Inc. director and Chief Executive Officer Martin Roper reported equity awards and updated holdings. He acquired 185,133 performance options at $16.91 per share and 25,945 shares of common stock through restricted stock units granted at $0.00 per share.
The filing notes that the restricted stock units vest in four equal annual installments, with shares automatically withheld at each vesting date to cover tax obligations. A performance-based stock option vested as to 185,133 shares on February 20, 2026 after its performance conditions were satisfied. The report also lists various non-qualified stock option holdings and indirect common stock holdings through family trusts and the reporting person’s spouse.
Vita Coco Company, Inc. director Jane Cecil Morreau reported option exercises and a related share sale. On February 23, 2026, she exercised non-qualified stock options in three steps, converting them into a total of 15,000 shares of common stock at $10.178 per share.
That same day she sold 15,000 shares of Vita Coco common stock at an average price of $53.91 per share in an open-market transaction executed under a Rule 10b5-1 trading plan. After these transactions, she directly owned 17,179 common shares of Vita Coco.
Vita Coco Company, Inc. director Kenneth Sadowsky reported an open-market sale of common stock. He sold 3,900 shares of common stock at a weighted average price of $55.64 per share in transactions executed under a pre-arranged Rule 10b5-1 trading plan.
After this sale, Sadowsky holds 604,366 shares of Vita Coco common stock directly. He also holds a non-qualified stock option for 27,300 shares that is fully vested and currently exercisable, providing additional potential equity exposure beyond his current common share holdings.
The Vita Coco Company, Inc. files its annual report describing a coconut-water focused beverage business built on an asset-light global supply chain and two segments: Americas and International. Coconut water accounts for 96% of revenue for the year ended December 31, 2025, making category health and brand strength critical.
The company highlights leadership of its Vita Coco brand in U.S. and U.K. coconut water, expansion into Private Label and PWR LIFT, and reliance on contract manufacturers and Tetra Pak packaging. It outlines extensive risk factors, including supply chain disruptions, raw material and freight cost volatility, customer concentration, intense competition, climate change, regulatory compliance, and obligations tied to its public benefit corporation and Certified B Corporation status.
The Vita Coco Company reported strong fourth quarter and full year 2025 results, with full year net sales of $610 million, up 18%, driven by 26% growth in Vita Coco Coconut Water. Full year net income rose to $71 million from $56 million, and diluted EPS increased to $1.19 from $0.94.
Non-GAAP Adjusted EBITDA grew to $98 million from $84 million, supported by higher pricing and volume, despite tariff and cost pressures. The company ended 2025 with no debt, cash and cash equivalents of $197 million, and executed $11.3 million of share repurchases, leaving $40.9 million authorized.
For fiscal 2026, Vita Coco expects net sales between $680 million and $700 million, gross margin of about 38%, and Adjusted EBITDA between $122 million and $128 million, reflecting continued growth in Vita Coco Coconut Water and improving Private Label trends.
Verlinvest Beverages SA, a Belgian company, reports beneficial ownership of 3,097,161 shares of common stock of The Vita Coco Company, Inc.. This represents 5.4% of the company’s common stock, based on 56,948,258 shares outstanding as of October 27, 2025.
Verlinvest reports sole voting and dispositive power over all of these shares, with no shared voting or investment authority and no group arrangements disclosed. The filing is an amendment to a prior ownership report, confirming Verlinvest as a significant but non-controlling shareholder.